Olpasiran
amgen
[]
see dr. michelle o'donoghue's late-breaking clinical trials presentation on reduction of lipoprotein(a) with small interfering rna: the results of the ocean(a)-dose trial, tomorrow at 5:13pm in main event i. #aha22 
Providing the latest news and research from the TIMI Study Group, an ARO affiliated with Brigham and Women’s Hospital and Harvard Medical School.